A meta-analysis of 20 publications revealed that in 1635 lung cancer patients of Asian (China) and European (Spain) origin, carriers of the T allele of the MTHFR rs1801133 SNP showed a higher risk of hematological toxicity during oxaliplatin-based therapy [64]. This evidence concerns the gene MTHFR and lung cancer.